SCHEMBL6407727

SCHEMBL6407727

Nc1nc(NC2CCN(S(=O)(=O)c3ccc(-c4ccccn4)s3)CC2)sc1C(=O)c1c(F)cccc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
CDK5 Q00535 6/20 0.46
CDK5R1 Q15078 6/20 0.46
CDK2 P24941 6/20 0.45
CDK4 P11802 4/20 0.45
CCND1 P24385 4/20 0.45
CDK1 P06493 2/20 0.45
CCNA2 P20248 4/20 0.44
CCNT1 O60563 2/20 0.42
CDK9 P50750 2/20 0.42
CDK6 Q00534 2/20 0.42
CDK11A Q9UQ88 2/20 0.42
MMP3 P08254 2/20 0.38
MMP1 P03956 1/20 0.38
MMP2 P08253 1/20 0.38
MMP7 P09237 1/20 0.38
CAPN1 P07384 1/20 0.38
MMP8 P22894 2/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6198232 0.86 CDK5 (0.48) ALDH1A1CDK5CDK5R1CDK2CDK4
SCHEMBL6197281 0.83 CDK4 (0.50) CDK5CDK5R1CDK2CDK4CCND1
SCHEMBL6196544 0.83 CDK4 (0.48) CDK5CDK5R1CDK2CDK4CCND1
SCHEMBL6198310 0.82 CDK5 (0.54) CDK5CDK5R1CDK2CDK4CCND1
SCHEMBL6193981 0.81 CDK5 (0.52) CDK5CDK5R1CDK2CDK4CCND1
SCHEMBL3384264 0.81 CDK2 (0.64) CDK5CDK5R1CDK2CDK4CCND1
SCHEMBL6199927 0.80 CDK2 (0.46) CDK5CDK5R1CDK2CDK4CCND1
SCHEMBL6196520 0.80 CDK5 (0.50) CDK5CDK5R1CDK2CDK4CCND1
Hydrochloric Acid SCHEMBL6407582 0.80 CDK2 (0.44) CDK5CDK5R1CDK2CDK4CCND1
SCHEMBL6197196 0.80 CDK2 (0.53) CDK5CDK5R1CDK2CDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050101595-A1 N-containing cycloalkyl-substituted amino-thiazole derivatives and pharmaceutical compositions for inhibiting cell proliferation and methods for their use PFIZER INC. 2005-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050101595-A1 N-containing cycloalkyl-substituted amino-thiazole derivatives and pharmaceutical compositions for inhibiting cell proliferation and methods for their use CCNI, MKI67, TK1 ALDH1A1 2277/4885CDK5 10/4885CDK5R1 125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.